UNSPSC 51382704: Sulindac sulfide

This classification denotes a cyclooxygenase inhibitor with the molecular formula C20H17FO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6UVA8S2DEY, chemically known as sulindac sulfide, (z)-, but more generally known as sulindac sulfide, which bears US NIH Compound Identifier 91605. European Medicines Agency schedules sulindac sulfide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10744MIG. Most nations, for tariff purposes, schedule sulindac sulfide under HS 29309085.

Sulindac sulfide bears US NLM identifiers UMLS ID C0075615 and NCI Concept Code C29854. SMILES: CC\1=C(C2CC(CCC2/C1=C\C3CCC(CC3)SC)F)CC(=O)O.

UNSPSC 51382704 Sulindac sulfide is a Commodity code that in recent state and local procurement activity maps to pharmaceutical and medical supply procurement, specifically for emergency response and community health initiatives. The single recent opportunity in the dataset shows Seminole County, Florida soliciting naloxone and drug deactivation systems through a competitive IFB process, indicating that the code's application in state and local practice extends beyond the narrow pharmaceutical chemical name to encompass broader medical countermeasure and harm-reduction product procurement. Work solicited under this code involves purchasing finished pharmaceutical products and medical devices for deployment to community health facilities, with vendors responsible for managing logistics, meeting regulatory compliance (including E-Verify and drug-free workplace requirements), and maintaining appropriate insurance coverage. The buying pattern reflects county-level health departments' role as primary issuers under this code tier.

Seminole County, Florida represents the only recent activity in the dataset. The Seminole County IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation structured pricing on a fixed-fee basis with a two-year initial term and one-year renewal option, included a three-month probationary termination clause, and flagged potential FEMA funding with associated federal compliance requirements. Bidders had to provide unit costs for each line item and submit electronically through the county's e-Procurement portal with all shipping and delivery costs included in their proposal. No explicit set-aside designations were specified. This narrow activity sample suggests limited recent state and local procurement volume under this code, or a data-capture gap between the code's nominal pharmaceutical scope and actual practice.